BRPI0407176A - Cepas de bifidobacterium possuindo a capacidade de produzir glutamina - Google Patents

Cepas de bifidobacterium possuindo a capacidade de produzir glutamina

Info

Publication number
BRPI0407176A
BRPI0407176A BR0407176-0A BRPI0407176A BRPI0407176A BR PI0407176 A BRPI0407176 A BR PI0407176A BR PI0407176 A BRPI0407176 A BR PI0407176A BR PI0407176 A BRPI0407176 A BR PI0407176A
Authority
BR
Brazil
Prior art keywords
ability
bifidobacterium
glutamine
bifidobacterium strains
strains possessing
Prior art date
Application number
BR0407176-0A
Other languages
English (en)
Inventor
G Ran Molin
Siv Ahrne
Bengt Jeppsson
Original Assignee
Probi Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Probi Ab filed Critical Probi Ab
Publication of BRPI0407176A publication Critical patent/BRPI0407176A/pt
Publication of BRPI0407176B1 publication Critical patent/BRPI0407176B1/pt
Publication of BRPI0407176B8 publication Critical patent/BRPI0407176B8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/51—Bifidobacterium
    • A23V2400/529—Infantis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mycology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Addiction (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Diabetes (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Urology & Nephrology (AREA)
  • Psychiatry (AREA)
  • Obesity (AREA)

Abstract

"CEPAS DE BIFIDOBACTERIUM POSSUINDO A CAPACIDADE DE PRODUZIR GLUTAMINA". A invenção refere-se às cepas de Bifidobacterium, especialmente das espécies de Bifidobacterium infantis, possuindo a capacidade de sobreviver no trato intestinal e produzir glutamina e opcionalmente arginina in vivo, bem como às composições compreendendo tais cepas.
BRPI0407176A 2003-01-31 2004-01-27 composições compreendendo uma ou mais cepas de bifidobacterium e seus usos BRPI0407176B8 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE0300245A SE526711C2 (sv) 2003-01-31 2003-01-31 Nya stammar av Bifidobacterium med förmåga att överleva i magtarmkanalen och producera glutamin in vivo, samt kompositioner och användningar därav
US44727403P 2003-02-14 2003-02-14
PCT/SE2004/000098 WO2004067731A1 (en) 2003-01-31 2004-01-27 New strains of bifidobacterium having the ability to produce glutamine

Publications (3)

Publication Number Publication Date
BRPI0407176A true BRPI0407176A (pt) 2006-02-07
BRPI0407176B1 BRPI0407176B1 (pt) 2018-05-08
BRPI0407176B8 BRPI0407176B8 (pt) 2021-05-25

Family

ID=20290264

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0407176A BRPI0407176B8 (pt) 2003-01-31 2004-01-27 composições compreendendo uma ou mais cepas de bifidobacterium e seus usos

Country Status (16)

Country Link
US (1) US7947482B2 (pt)
EP (1) EP1587913B1 (pt)
JP (1) JP4540664B2 (pt)
CN (1) CN100558883C (pt)
AT (1) ATE496115T1 (pt)
AU (1) AU2004208084B2 (pt)
BR (1) BRPI0407176B8 (pt)
CA (1) CA2514659C (pt)
DE (1) DE602004031079D1 (pt)
DK (1) DK1587913T3 (pt)
ES (1) ES2362496T3 (pt)
PL (1) PL212096B1 (pt)
RU (1) RU2352628C2 (pt)
SE (1) SE526711C2 (pt)
WO (1) WO2004067731A1 (pt)
ZA (1) ZA200505777B (pt)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2622951A1 (en) 2005-09-28 2007-04-05 Nordisk Rebalance A/S Treatment of ibd and ibs using both probiotic bacteria and fermented cereal as treatment effectors
AU2006297896B2 (en) * 2005-10-06 2011-12-08 Probi Ab Use of lactobacillus for treatment of autoimmune diseases
CN105671120B (zh) * 2010-07-05 2019-02-19 株式会社明治 具有肠内腐败物质的减少作用的双歧杆菌
CL2010001124A1 (es) 2010-10-14 2011-01-21 Univ De Concepcion 50% Ma Loreto Ormeno 50% Alimento funcional probiotico que comprende cepas viables de lactobacillus sp.; uso de dicho alimento funcional para contrarestar los efectos colaterales de la quimioterapia.
KR20130049671A (ko) 2011-11-04 2013-05-14 한미사이언스 주식회사 생리활성 폴리펩타이드 결합체 제조 방법
CN103131647B (zh) * 2011-11-29 2017-06-27 上海上药信谊药厂有限公司 婴儿双歧杆菌及其制剂
WO2013130773A2 (en) 2012-02-29 2013-09-06 Ethicon Endo-Surgery, Inc. Compositions of microbiota and methods related thereto
AR090281A1 (es) 2012-03-08 2014-10-29 Hanmi Science Co Ltd Proceso mejorado para la preparacion de un complejo polipeptidico fisiologicamente activo
CA2964480A1 (en) 2014-10-31 2016-05-06 Whole Biome Inc. Methods and compositions relating to microbial treatment and diagnosis of disorders
WO2019046646A1 (en) 2017-08-30 2019-03-07 Whole Biome Inc. METHODS AND COMPOSITIONS FOR THE TREATMENT OF MICROBIOMA ASSOCIATED DISORDERS
CN108330166A (zh) * 2017-09-06 2018-07-27 深圳市百澳飞生物技术有限公司 一种酶制剂的饲用活性评估方法
JP7811843B2 (ja) 2018-07-19 2026-02-06 ペンデュラム セラピューティクス， インコーポレイテッド 微生物生着のための方法および組成物
RU2699967C1 (ru) * 2018-12-25 2019-09-11 Федеральное государственное бюджетное образовательное учреждение высшего образования "Астраханский государственный медицинский университет" Министерства здравоохранения Российской Федерации (ФГБОУ ВО Астраханский ГМУ Минздрава России) Способ комплексного лечения энтеральной недостаточности у детей с тяжелой термической травмой
US11045507B2 (en) 2019-02-21 2021-06-29 Ewelina Sosnowska-Turek Bifidobacterium animalis AMT30 strain and the composition containing the strain of Bifidobacterium animalis AMT30

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59155321A (ja) * 1983-02-25 1984-09-04 Riyoushiyoku Kenkyukai 整腸用製剤
DE3406772A1 (de) * 1984-02-24 1986-03-13 Angelo 8137 Berg Schuler Diaetetisches mittel zur herabsetzung der harnstoffkonzentration in koerperfluessigkeiten und seine herstellung
SE9002732D0 (sv) * 1990-08-24 1990-08-24 Kabivitrum Ab Product containing growth factor
IT1254210B (it) * 1992-02-10 1995-09-14 Simone Claudio De Composizioni dietetiche e/o farmaceutiche a base di batteri lattici liofilizzati, loro preparazione e impiego
JP3623977B2 (ja) * 1993-10-29 2005-02-23 明治乳業株式会社 潰瘍性大腸炎治療剤
JP4852681B2 (ja) * 1996-02-28 2012-01-11 雪印メグミルク株式会社 腸管内細胞溶解活性抑制剤
IT1288119B1 (it) * 1996-06-28 1998-09-10 Renata Maria Anna Ve Cavaliere Composizioni dietetiche da utilizzare nell'alimentazione per via enterica
RU2112034C1 (ru) * 1996-12-26 1998-05-27 Московский научно-исследовательский институт эпидемиологии и микробиологии им.Г.Н.Габричевского Штамм bifidobacterium infantis 73-15, используемый для приготовления бифидосодержащих бактерийных препаратов и продуктов лечебно-диетического питания
CN1099289C (zh) * 1997-08-01 2003-01-22 北京东方百信生物技术有限公司 改善肠道生态平衡的微生物制剂及其工艺
US6203797B1 (en) * 1998-01-06 2001-03-20 Stephen C. Perry Dietary supplement and method for use as a probiotic, for alleviating the symptons associated with irritable bowel syndrome
ID29150A (id) * 1999-01-15 2001-08-02 Entpr Ireland Cs Penggunaan lactobacillus salivarius
EP1206523B1 (en) * 1999-08-05 2009-03-11 Société des Produits Nestlé S.A. Bifidobacteria preventing diarrhea caused by pathogenic bacteria
US6468525B1 (en) * 1999-08-10 2002-10-22 Renew Life, Inc. Probiotic formulation
EP1292189A4 (en) 2000-05-03 2003-08-13 Univ Maryland ORAL COMPOSITION OF GRAM (+) BACTERIA AND GLUTAMINE FOR THE PREVENTION AND / OR TREATMENT OF GASTROINTESTINALS
AU2001265253A1 (en) * 2000-07-07 2002-01-21 First Circle Medical, Inc. Treatment of hiv using hyperthermia
JP2002186422A (ja) * 2000-12-22 2002-07-02 Morinaga Milk Ind Co Ltd ラクトバシラス・ガッセリ及びビフィドバクテリウム属の菌を含有する非発酵食品
FI109602B (fi) 2001-01-25 2002-09-13 Valio Oy Probioottiyhdistelmä
ATE375164T1 (de) 2001-02-06 2007-10-15 Nestle Sa Endotoxin-bindung durch milchsäurebakterien und bifidobacteria
US20030017192A1 (en) * 2001-06-19 2003-01-23 Hanny Kanafani Process for producing extended shelf-life ready-to-use milk compositions containing probiotics
US20030092163A1 (en) * 2001-07-26 2003-05-15 Collins John Kevin Probiotic bifidobacterium strains
JP3364491B2 (ja) * 2002-07-25 2003-01-08 株式会社アトリエ・ド・フロマージュ ヨーグルトおよびその製造方法

Also Published As

Publication number Publication date
US20060269533A1 (en) 2006-11-30
DE602004031079D1 (de) 2011-03-03
BRPI0407176B8 (pt) 2021-05-25
CN100558883C (zh) 2009-11-11
ATE496115T1 (de) 2011-02-15
EP1587913A1 (en) 2005-10-26
DK1587913T3 (da) 2011-04-11
JP4540664B2 (ja) 2010-09-08
RU2005127331A (ru) 2006-01-27
EP1587913B1 (en) 2011-01-19
RU2352628C2 (ru) 2009-04-20
BRPI0407176B1 (pt) 2018-05-08
ES2362496T3 (es) 2011-07-06
SE526711C2 (sv) 2005-10-25
AU2004208084A1 (en) 2004-08-12
CA2514659C (en) 2014-07-08
WO2004067731A1 (en) 2004-08-12
PL212096B1 (pl) 2012-08-31
CA2514659A1 (en) 2004-08-12
SE0300245L (sv) 2004-08-01
SE0300245D0 (sv) 2003-01-31
CN1777670A (zh) 2006-05-24
US7947482B2 (en) 2011-05-24
JP2006516405A (ja) 2006-07-06
PL378435A1 (pl) 2006-04-03
AU2004208084B2 (en) 2008-10-09
ZA200505777B (en) 2007-12-27

Similar Documents

Publication Publication Date Title
CY1118984T1 (el) Παρασκευη ενεργων, ακρως φωσφορυλιωμενων, ανθρωπινων λυσοσωμικων ενζυμων σουλφατασης και χρησεις αυτων
MY137619A (en) 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions
BRPI0417826A (pt) bifidobactéria pseudolongum probiótica canina
ECSP055725A (es) Formulaciones nutricionales que contienen sustancias simbióticas
MXPA05009015A (es) Nuevos derivados de bencimidazol e imidazo-piridina y su utilizacion como medicamentos.
MY151984A (en) Non-anticoagulant polysaccharide compositions
UA91854C2 (ru) Фунгицидная комбинация действующих веществ
BRPI0407176B8 (pt) composições compreendendo uma ou mais cepas de bifidobacterium e seus usos
ATE437663T1 (de) Legierungszusammensetzungen und diese enthaltende vorrichtungen
ZA200704247B (en) Stress tolerant cotton plants
BR0116349A (pt) Compostos probióticos derivados da cepa ke01 de lactobacillus casei
CY1107671T1 (el) Νεα συνθεση γαλακτοολιγοσακχαριτη και η παρασκευη της
DE602007010764D1 (en) Benzamidglucokinaseaktivatoren
RU2013114313A (ru) Противокариесные композиции и пробиотики/пребиотики
BRPI0511615B8 (pt) forma de administração oral compreendendo bactéria probiótica
EP2223697A4 (en) MILKY ACID BACTERIUM CONTAINING PREPARATION
UY28313A1 (es) Nonadepsipeptidos acilados
IL194353A0 (en) Lysobactin amides
TW200621799A (en) Acylated nonadepsipeptides II
BR0115534A (pt) Luciferases isoladas assim como seu emprego
ATE462779T1 (de) Nukleinsäurefreie ghost zusammensetzungen
ATE433459T1 (de) Desoxo-nonadepsipeptide
ATE407126T1 (de) Herstellung von (s)-4-fluormethyl-dihydro-furan-2-on
ATE455789T1 (de) Substituierte nonadepsipeptide
ATE369145T1 (de) Aus einer bifidobakterien-kultur gewonnener immunomodulator und diesen enthaltende zusammensetzungen

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 7A ANUIDADE.

B08H Application fees: decision cancelled [chapter 8.8 patent gazette]

Free format text: REFERENTE AO DESPACHO PUBLICADO NA RPI 2159 DE 22/05/2012.

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B15K Others concerning applications: alteration of classification

Ipc: A61K 35/745 (2015.01), A23L 33/135 (2016.01), C12N

B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]
B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 27/01/2004 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 20A ANUIDADE.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2759 DE 21-11-2023 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.